Digital Imaging Aid for Assessment of Cervical Dysplasia

Status Terminated

Clinical Trial Summary

The overall objective of this study is to evaluate whether polarized or green filtered digital imaging can assist clinicians to screen for premalignant lesions in the cervix.

The specific aims of the study are:

- To compare polarized and green filtered digital images of the cervix, to standard white light images, colposcopic evaluation and to pathologic analysis of biopsied tissue.

- To develop algorithms to discriminate between normal and abnormal tissue based on digital images of the cervix.

- To analyze digital images to determine which types of optical information yield the most diagnostically useful data.

Clinical Trial Description

If you agree to take part in this study, digital imaging will be performed for research purposes, after your routine colposcopy of your cervix.

VISUAL DETECTION OF PRECANCEROUS LESIONS:

Reflectance (the ability of an area to reflect light) imaging helps doctors visually tell the difference between precancerous tissue, cancerous tissue, and normal tissue in the cervix. Researchers want find out whether a digital camera image can be as effective as colposcopy at screening for precancerous tissue.

STUDY PARTICIPATION:

You will be seen in the clinic during a routine visit. Your cervix will first be examined by the clinician using a standard white light headlamp, and the image will be recorded.

Your cervix will then be re-examined with the digital camera, which will involve the use of different types of light (standard white light, green filtered light, cross and parallel polarized light). These digital images will be taken before and after acetic acid (vinegar) is applied.

Researchers will use these images to make comparison studies with the colposcopy procedure.

LENGTH OF STUDY:

Your participation will be finished on this study once your cervix has been examined with the digital camera.

This is an investigational study. Up to patients 20 will take part in this study. All will be enrolled at M. D. Anderson. ;

Study Design

Observational Model: Case-Only, Time Perspective: Prospective

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00511758
Study type	Observational
Source	M.D. Anderson Cancer Center
Contact
Status	Terminated
Phase	N/A
Start date	June 2007
Completion date	May 2009

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04098744` - Artesunate Vaginal Inserts for the Treatment of Cervical Intraepithelial Neoplasia (CIN2/3)	Phase 2
Recruiting	`NCT04226313` - Self-sampling for Non-attenders to Cervical Cancer Screening	N/A
Completed	`NCT01435590` - Endocervical Evaluation With the Curette Versus Cytobrush for the Diagnosis of Dysplasia of the Uterine Cervix	N/A
Completed	`NCT00212381` - Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia	Phase 3
Completed	`NCT05234112` - Prevention and Screening Towards Elimination of Cervical Cancer	N/A
Completed	`NCT04133610` - HPVPro Study: Comparison of HPV Detection in Clinician-collected Cervical Swabs and Self-sampled Cervicovaginal Swabs	N/A
Recruiting	`NCT06086054` - Effect of a Childcare Resource on Cervical Cancer Prevention	N/A
Not yet recruiting	`NCT04191603` - TWO DİFFERENT ELECTROSURGERY DEVICES AS MONOPOLAR HOOC AND PLASMAKINETIC BIPOLAR SPATULA EFFECTIVENESS DURING COLPOTOMY	N/A
Active, not recruiting	`NCT02250716` - A Comparison of Immediate Treatment of CIN1 With Cryotherapy and 12 Month Cytology Follow up in HIV Seropositive Women	N/A
Active, not recruiting	`NCT06452004` - Validation of Artificial Intelligence as Decision Support System in VIA (PRESCRIP-TEC)	N/A
Recruiting	`NCT05640700` - Vaginal Microbiome and HPV Pre-malignant and Cervical Dysplasia
Completed	`NCT03502798` - Coherence Imaging of the Cervical Epithelium With Scanning a/LCI	N/A
Recruiting	`NCT06137950` - Interferon Alpha Therapy for Cervical CINI and HPV Infection	Phase 1
Withdrawn	`NCT01925378` - A Phase II Single-arm Intervention Trial of Nelfinavir in Patients With Grade 2/3 or 3 Cervical Intraepithelial Neoplasia	Phase 2
Completed	`NCT01766284` - Study of the Diagnostic Efficacy of "Real Time" Niris 1300e Optical Coherence Tomography (OCT) Imaging System in the Management of Pre-invasive and Invasive Neoplasia of the Uterine Cervix	N/A
Completed	`NCT01524003` - Chinese Cancer Prevention Study(CHICAPS)	N/A
Completed	`NCT04679675` - Self-Testing Options in the Era of Primary HPV Screening for Cervical Cancer Trial	N/A
Recruiting	`NCT04045652` - Factors Predicting Persistence of Oncogenic HPV and Cervical Dysplasia in HIV Infected Kenyan Women
Completed	`NCT05756192` - Educational Video's Impact on Knowledge Regarding Cervical Cancer Screening	N/A
Enrolling by invitation	`NCT04915495` - The Use of the LuViva Advanced Cervical Scan to Identify Women at High-Risk for Cervical Neoplasia	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.